Olfr559 Inhibitors
Olfr559, a G protein-coupled receptor primarily implicated in olfactory signal transduction, holds a critical role in the intricate processes of sensory perception. As a member of the olfactory receptor family, Olfr559 is positioned within the olfactory epithelium, where it plays a key role in detecting and transducing olfactory stimuli. Olfactory receptors, including Olfr559, are vital components of the sensory system, facilitating the recognition of diverse odorants present in the environment. The activation of Olfr559 initiates a cascade of signaling events that ultimately lead to the generation of neuronal signals, contributing to the perception of specific odors. In terms of its functional significance, Olfr559 is integral to the sophisticated olfactory system, which enables organisms to discern and respond to a myriad of odorant molecules. The binding of odorants to Olfr559 triggers a series of intracellular events, leading to the activation of downstream signaling pathways and subsequent transmission of olfactory signals to the brain. The specificity of Olfr559 in recognizing distinct odorants underlines its pivotal role in shaping the olfactory landscape, influencing behaviors related to food preferences, environmental cues, and social interactions. Understanding the molecular intricacies of Olfr559 and its associated pathways is crucial for unraveling the complexities of olfactory perception at the molecular level.
In the context of inhibition, various chemical agents have been explored to modulate the expression and function of Olfr559. These agents exert their influence through precise interactions with signaling pathways associated with Olfr559, ultimately leading to a downregulation of its activity. The inhibition of Olfr559 is achieved through indirect means, where these chemicals impact specific intracellular cascades. For instance, inhibitors targeting the MAPK/ERK pathway disrupt downstream signaling events linked to Olfr559, resulting in a modulation of its expression and function. Similarly, interference with TGF-β, PI3K/AKT, and JNK signaling pathways provides indirect inhibitory effects on Olfr559, highlighting the intricate network of interactions that govern its activity. These mechanisms of inhibition showcase the potential for fine-tuned control over Olfr559, contributing to a deeper understanding of olfactory processes and their regulation at the molecular level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Pyrithione inhibits Olfr559 indirectly by modulating intracellular zinc levels. As a zinc ionophore, it enhances cellular zinc uptake, leading to downregulation of pathways essential for Olfr559 expression, effectively reducing the protein's activity. | ||||||
ICI 182,780 | 129453-61-8 | sc-203435 sc-203435A | 1 mg 10 mg | $83.00 $187.00 | 34 | |
ICI 182,780 is a selective estrogen receptor antagonist that impacts estrogen signaling pathways associated with Olfr559. Its inhibitory effect is achieved by disrupting estrogen-mediated processes, thereby influencing the gene expression and function of Olfr559. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin acts as a potent phosphoinositide 3-kinase (PI3K) inhibitor, disrupting the PI3K/AKT signaling pathway linked to Olfr559. By hindering this pathway, Wortmannin indirectly suppresses the expression and activity of Olfr559, providing an inhibitory effect. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits Olfr559 through modulation of Rho-associated protein kinase (ROCK) signaling. By targeting ROCK, Y-27632 disrupts downstream signaling cascades, influencing Olfr559 expression and function indirectly through alterations in cellular cytoskeletal dynamics. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 functions as a MEK inhibitor, impacting the MAPK/ERK pathway associated with Olfr559. By blocking MEK activity, U0126 disrupts the downstream signaling, leading to indirect inhibition of Olfr559 expression and function within the cellular context. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 serves as a selective inhibitor of TGF-β receptor I (ALK5), affecting TGF-β signaling pathways linked to Olfr559. Its indirect inhibitory effect is exerted by interfering with TGF-β-mediated processes, ultimately influencing Olfr559 expression and functional outcomes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits Olfr559 indirectly by targeting c-Jun N-terminal kinase (JNK) signaling. Through inhibition of JNK, SP600125 disrupts downstream events, leading to alterations in Olfr559 expression and function, providing an indirect inhibitory impact on the target protein. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Bay 11-7082 acts as an inhibitor of nuclear factor-kappa B (NF-κB) activation. By modulating NF-κB signaling, Bay 11-7082 indirectly influences Olfr559 expression and function. Its inhibitory mechanism involves interference with the transcriptional regulation associated with Olfr559. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 functions as a PI3K inhibitor, impacting the PI3K/AKT pathway involved in Olfr559 signaling. Through inhibition of PI3K, LY294002 disrupts downstream cascades, leading to indirect inhibition of Olfr559 expression and functional consequences within the cellular context. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 serves as a MEK inhibitor, affecting the MAPK/ERK pathway associated with Olfr559. Its indirect inhibitory effect is exerted by blocking MEK activity, disrupting the downstream signaling, and influencing Olfr559 expression and functional outcomes within the cellular context. | ||||||